Targeted Drug ROS1 Inhibitors for NSCLC Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Crizotinib
1.2.3 Lorlatinib
1.2.4 Entrectinib
1.2.5 Other
1.3 Market by Application
1.3.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Squamous Cell Carcinoma of NSCLC
1.3.3 Adenocarcinoma of NSCLC
1.3.4 Large Cell Carcinoma of NSCLC
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Perspective (2017-2028)
2.2 Targeted Drug ROS1 Inhibitors for NSCLC Growth Trends by Region
2.2.1 Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Region (2017-2022)
2.2.3 Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Region (2023-2028)
2.3 Targeted Drug ROS1 Inhibitors for NSCLC Market Dynamics
2.3.1 Targeted Drug ROS1 Inhibitors for NSCLC Industry Trends
2.3.2 Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers
2.3.3 Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges
2.3.4 Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drug ROS1 Inhibitors for NSCLC Players by Revenue
3.1.1 Global Top Targeted Drug ROS1 Inhibitors for NSCLC Players by Revenue (2017-2022)
3.1.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Players (2017-2022)
3.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Drug ROS1 Inhibitors for NSCLC Revenue
3.4 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Concentration Ratio
3.4.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug ROS1 Inhibitors for NSCLC Revenue in 2021
3.5 Targeted Drug ROS1 Inhibitors for NSCLC Key Players Head office and Area Served
3.6 Key Players Targeted Drug ROS1 Inhibitors for NSCLC Product Solution and Service
3.7 Date of Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug ROS1 Inhibitors for NSCLC Breakdown Data by Type
4.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Type (2017-2022)
4.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2023-2028)
5 Targeted Drug ROS1 Inhibitors for NSCLC Breakdown Data by Application
5.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Application (2017-2022)
5.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2017-2028)
6.2 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type
6.2.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022)
6.2.2 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028)
6.2.3 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Type (2017-2028)
6.3 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application
6.3.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022)
6.3.2 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028)
6.3.3 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Application (2017-2028)
6.4 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country
6.4.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022)
6.4.2 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2017-2028)
7.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type
7.2.1 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022)
7.2.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028)
7.2.3 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Type (2017-2028)
7.3 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application
7.3.1 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022)
7.3.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028)
7.3.3 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Application (2017-2028)
7.4 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country
7.4.1 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022)
7.4.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2017-2028)
8.2 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type
8.2.1 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Type (2017-2028)
8.3 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application
8.3.1 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Application (2017-2028)
8.4 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region
8.4.1 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2017-2028)
9.2 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type
9.2.1 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022)
9.2.2 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028)
9.2.3 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Type (2017-2028)
9.3 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application
9.3.1 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022)
9.3.2 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028)
9.3.3 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Application (2017-2028)
9.4 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country
9.4.1 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022)
9.4.2 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2017-2028)
10.2 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type
10.2.1 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Type (2017-2028)
10.3 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application
10.3.1 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Application (2017-2028)
10.4 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country
10.4.1 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.1.4 Roche Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.2.4 Pfizer Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Beacon Pharma Limited
11.3.1 Beacon Pharma Limited Company Details
11.3.2 Beacon Pharma Limited Business Overview
11.3.3 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.3.4 Beacon Pharma Limited Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
11.3.5 Beacon Pharma Limited Recent Developments
11.4 Drug International Limted
11.4.1 Drug International Limted Company Details
11.4.2 Drug International Limted Business Overview
11.4.3 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.4.4 Drug International Limted Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
11.4.5 Drug International Limted Recent Developments
11.5 Incepta Pharmaceuticals
11.5.1 Incepta Pharmaceuticals Company Details
11.5.2 Incepta Pharmaceuticals Business Overview
11.5.3 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.5.4 Incepta Pharmaceuticals Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
11.5.5 Incepta Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Crizotinib
Table 3. Key Players of Lorlatinib
Table 4. Key Players of Entrectinib
Table 5. Key Players of Other
Table 6. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2017-2022)
Table 10. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2023-2028)
Table 12. Targeted Drug ROS1 Inhibitors for NSCLC Market Trends
Table 13. Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers
Table 14. Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges
Table 15. Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints
Table 16. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Share by Players (2017-2022)
Table 18. Global Top Targeted Drug ROS1 Inhibitors for NSCLC by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2021)
Table 19. Ranking of Global Top Targeted Drug ROS1 Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Targeted Drug ROS1 Inhibitors for NSCLC Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Targeted Drug ROS1 Inhibitors for NSCLC Product Solution and Service
Table 23. Date of Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2017-2022)
Table 27. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2023-2028)
Table 29. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Share by Application (2017-2022)
Table 31. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Share by Application (2023-2028)
Table 33. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2023-2028) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 66. Roche Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 67. Roche Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 71. Pfizer Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. Beacon Pharma Limited Company Details
Table 74. Beacon Pharma Limited Business Overview
Table 75. Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 76. Beacon Pharma Limited Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 77. Beacon Pharma Limited Recent Developments
Table 78. Drug International Limted Company Details
Table 79. Drug International Limted Business Overview
Table 80. Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 81. Drug International Limted Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 82. Drug International Limted Recent Developments
Table 83. Incepta Pharmaceuticals Company Details
Table 84. Incepta Pharmaceuticals Business Overview
Table 85. Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 86. Incepta Pharmaceuticals Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
Table 87. Incepta Pharmaceuticals Recent Developments
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Type: 2021 VS 2028
Figure 2. Crizotinib Features
Figure 3. Lorlatinib Features
Figure 4. Entrectinib Features
Figure 5. Other Features
Figure 6. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Application: 2021 VS 2028
Figure 7. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 8. Adenocarcinoma of NSCLC Case Studies
Figure 9. Large Cell Carcinoma of NSCLC Case Studies
Figure 10. Targeted Drug ROS1 Inhibitors for NSCLC Report Years Considered
Figure 11. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region: 2021 VS 2028
Figure 14. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Players in 2021
Figure 15. Global Top Targeted Drug ROS1 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Targeted Drug ROS1 Inhibitors for NSCLC Revenue in 2021
Figure 17. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 19. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 20. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 21. United States Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 25. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 26. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 27. Germany Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Region (2017-2028)
Figure 37. China Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 47. Mexico Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Country (2017-2028)
Figure 53. Turkey Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Roche Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
Figure 58. Beacon Pharma Limited Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
Figure 59. Drug International Limted Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
Figure 60. Incepta Pharmaceuticals Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
